Who We Are
A Leading Nicotine Alternative Products Solution Provider
Established in April 2002 and restructured in 2007, Beijing Sciecure Pharmaceutical Co., Ltd. has continuously pioneered the development of innovative pharmaceutical solutions. Beijing Sciecure Pharmaceutical Co., Ltd's cutting-edge manufacturing facility, a hub of innovation and excellence. Our factory, located in the heart of Beijing at Zhongbei Industrial Park, Beishicao Town, Shunyi District, China, is a symbol of our unwavering commitment to quality and safety.
As a testament to our commitment to innovation and growth, we proudly introduce STW: Sciecure Technology Worldwide, a Business Unit dedicated to the rapidly expanding realm of nicotine products, including synthetic and nicotine pouches. This fresh and dynamic business unit is an extension of Beijing Sciecure's legacy and is poised for rapid growth in nicotine alternatives. With a strong global presence, STW Technologies has firmly established itself as a leading nicotine alternative products solution provider, offering high-quality nicotine products including oral nicotine pouches, nicotine salt and synthetic nicotine as raw materials.
Powered by
Core Values
Innovation
We have a team of experts who are passionate about exploring new ways to develop and manufacture nicotine products that are not only enjoyable but also safe. We focus on innovation to ensure that we remain ahead of the competition and continue to provide our customers with the best products available on the market today.
Transparency
We are a trusted brand that is dedicated to creating safe and high-quality products. Our commitment to transparency and reliability is a key part of our brand promise, and our customers can always trust us to deliver. From traditional tobacco products to vape liquids, we offer a wide range of nicotine products to suit your needs.
Excellence
For us, it’s not just about creating a range of nicotine products, it’s about making sure that each and every product meet our high standards of excellence. Precision and attention to detail are of utmost importance in our manufacturing process. We aim to exceed your expectations by delivering only the best, not just better.
Exclusive Drug Approval
We are honored to have obtained an exclusive drug for synthetic nicotine and nicotine granules. Our drug approval number, H20041567, reflects our unwavering dedication to maintaining and exceeding international quality and safety standards.
TMPF successfully Submission for USA FDA
Beijing Sciecure has once again demonstrated its commitment to excellence by successfully submitting the Technical Product Master File (TPMF) to the United States Food and Drug Administration (FDA). What makes this accomplishment truly remarkable is that Beijing Sciecure is the first and only pharmaceutical company in China to receive FDA acceptance of their TPMF, as confirmed by the FDA Submission Tracking Number (STN): MF0000868
